Stock Events

Stock Events

Regulus Therapeutics (RGLS) Q1 2025 Earnings

13MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.29

-0.24

-0.19

-0.15

Details

Expected EPS

-0.21

Actual EPS

-0.2

Surprise EPS

0.01

Surprise Percent

+4.76%

Description

Regulus Therapeutics (RGLS) has reported earnings of -0.2 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.